 NEW YORK, April 07, 2021 GLOBE NEWSWIRE -- Anavex Life Sciences Corp. Anavex or the Company Nasdaq: AVXL, a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimers disease, Parkinsons disease, Rett syndrome and other central nervous system CNS diseases, today announced that its President and Chief Executive Officer, Christopher U. Missling, PhD, will join a panel discussion titled, Establishing Mutually Beneficial Collaborations, at the World EPA Congress 2021 event on Thursday, April 15t h at 8:55 a.m. EDT 14:55 CET. 